These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2000673)

  • 1. Gleason's histologic grading as clinical prognostic marker in patients with advanced prostatic carcinoma.
    Schwartz CB; Bekirov H; Melman A
    Urology; 1991 Mar; 37(3):198-201. PubMed ID: 2000673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between histologic grading and prognosis of prostatic cancer--comparing the grading system of the Japanese general rules of prostatic cancer with Gleason's grading].
    Hioki T; Sugimura Y; Sakurai M; Hayashi N; Tochigi H; Kawamura J; Yatani R
    Hinyokika Kiyo; 1990 Aug; 36(8):921-6. PubMed ID: 2239593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
    Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS
    Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with Gleason's histopathologic grading in prostatic cancer.
    Kramer SA; Spahr J; Brendler CB; Glenn JF; Paulson DF
    J Urol; 1980 Aug; 124(2):223-5. PubMed ID: 6995622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relation of serum prostate-specific antigen and the Gleason grade in patients with prostatic carcinoma].
    Zivković S; Velicković L; Kostov M; Stojanović N
    Vojnosanit Pregl; 2003; 60(4):449-54. PubMed ID: 12958804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic carcinoma with emphasis on Gleason's Grading: an institution based experience.
    Ahmed Z; Muzaffar S
    J Pak Med Assoc; 2002 Feb; 52(2):54-6. PubMed ID: 12073709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD10 expression pattern in prostatic adenocarcinoma: Elucidation of differences between Gleason's grades.
    Kaur M; Verma S; Gupta R; Pant L; Singh S
    Malays J Pathol; 2018 Apr; 40(1):57-60. PubMed ID: 29704385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between histological grading and the prognosis of prostatic carcinoma--a comparative study of the Japanese General Rules of Prostatic Cancer (JGRPC) and Gleason's classification].
    Uchida T; Go M; Nakajo H; Takagi Y; Murayama M; Honda N; Igarashi M; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1988 Jan; 34(1):116-22. PubMed ID: 3376792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gleason's score: update in 2008].
    Molinié V
    Ann Pathol; 2008 Oct; 28(5):350-3. PubMed ID: 19068389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical studies on endocrine therapy of prostatic carcinoma (1): Multivariate analyses of prognostic factors in patients with prostatic carcinoma given endocrine therapy].
    Kumamoto Y; Tsukamoto T; Umehara T; Shimazaki J; Fuse H; Ohshima H; Takeuchi H; Yoshida O; Okada K; Saito Y
    Hinyokika Kiyo; 1990 Mar; 36(3):275-84. PubMed ID: 2191569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reproducibility and prognostic value of Gleason's and Gaeta's histological grades in prostatic carcinoma].
    Rousselet MC; Saint-André JP; Six P; Soret JY
    Ann Urol (Paris); 1986; 20(5):317-22. PubMed ID: 3777875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostatic carcinoma: histoprognosis, prognostic value of Gleason's index].
    Saint-André JP; Rousselet MC; Six P; Bertrand G; Soret JY
    Bull Cancer; 1985; 72(5):414-22. PubMed ID: 4074910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gleason's score in prostate adenocarcinoma and its application].
    Cao D
    Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):145-8. PubMed ID: 24842010
    [No Abstract]   [Full Text] [Related]  

  • 14. [Multivariate analysis of prognostic factors in patients with prostatic cancer].
    Miyamoto T; Yuasa M; Furukawa A; Tamura M; Kawanishi Y; Numata A; Imagawa A; Kagawa S
    Hinyokika Kiyo; 1991 Dec; 37(12):1663-8. PubMed ID: 1785390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with Gleason histopathologic grading of prostatic cancer in Japan.
    Nemoto R; Uchida K; Harada M; Koiso K; Abe R; Kato T
    Urology; 1987 Nov; 30(5):436-40. PubMed ID: 3672676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer of the prostate: reclaiming Gleason's sum].
    Espuela Orgaz R; Nogueras Gimeno MA; Passas Martínez J; Ruiz Liso JM; Sanz Anquela M
    Actas Urol Esp; 1982; 6(6):317-22. PubMed ID: 7183177
    [No Abstract]   [Full Text] [Related]  

  • 17. [Gleason's grading of prostatic cancer: a current perspective].
    Cheng L; Wang X; Zhu YL; Zhang JM; Lopez-Beltran A; Montironi R
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):577-80. PubMed ID: 22177238
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prognostic evaluation of prostatic cancer by Gleason's histopathologic grading and tissue DHT level].
    Kohama Y; Morioka M; Kamei Y; Yamamoto Y; Sen Y; Fujita Y; Sonobe H
    Nihon Hinyokika Gakkai Zasshi; 1988 Jul; 79(7):1228-34. PubMed ID: 3246814
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation-treated carcinoma of prostate. Comparison of survival of black and white patients by Gleason's grading system.
    Aziz H; Rotman M; Thelmo W; Chen P; Choi KN; Khil SU; Laungani GB; Brandys M; Ayr G; Macchia RJ
    Am J Clin Oncol; 1988 Apr; 11(2):166-71. PubMed ID: 3358363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flow cytometry in prostate cancer. Evaluation of its feasibility for biopsy specimens and correlation with grading].
    Ferrara G; Monaco R; Capasso A; Bellomo PF; Fruttero A; Pugno F; Nappi O; Ruà S
    Pathologica; 1998 Feb; 90(1):14-9. PubMed ID: 9628974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.